I'rom Group Co., Ltd. (2372.T) JPX

2,790.00

-3(-0.11%)

Updated at May 09 03:30PM

Currency In JPY

I'rom Group Co., Ltd.

Address

Iidabashi Grand Bloom

Tokyo, 102-0071

Japan

Phone

81 3 3264 3148

Sector

Healthcare

Industry

Medical - Care Facilities

Employees

1029

First IPO Date

February 01, 2005

Key Executives

NameTitlePayYear Born
Mr. Toyotaka MoriChief Executive Officer, President & Director01958
Mr. Toshiya HaraExecutive Vice President of Sales & Director01970
Mr. Yasutomo YamauchiHead of Legal Affairs Division, International HR Management Division & Director01971
Mr. Hiroaki InukaiSenior MD & Director01966
Zhu AfengExecutive Vice President & Director01957
Mr. Kiyoshi WatanabeExecutive Vice President, Head of the Finance and Business Management & Director01958
Mr. Masaaki MatsushimaExecutive Vice President & Director01964
Mr. Shuichi KojimaSenior MD & Director01968

Description

I'rom Group Co., Ltd. engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. The company engages in the development of medical technologies, such as regenerative medicine and gene therapy for obstructive arteriosclerosis, retinitis pigmentosa, and human immunodeficiency virus infection and acquired immune deficiency syndrome, as well as Sendai virus vector and CytoTune-iPS, a kit for generating iPS cells. It also supports medical institutions in conducting clinical trials; provides clinical trial support services for new drug development and medical equipment for cancer, and rare and intractable diseases; and establishes and operates clinic malls. The company was formerly known as I'Rom Holdings Co., Ltd. and changed its name to I'rom Group Co., Ltd. in July 2015. I'rom Group Co., Ltd. was founded in 1997 and is headquartered in Tokyo, Japan.